Jo M. Garner, Ph.D.
Affiliations: | 2014 | Cancer and Developmental Biology | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Cell Biology, Oncology, Human DevelopmentGoogle:
"Jo Garner"Parents
Sign in to add mentor| Lawrence Pfeffer | grad student | 2014 | UTHSC | |
| (Molecular Characterization of Glioblastoma Cancer Stem Cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Garner JM, Herr MJ, Hodges KB, et al. (2016) The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma. Biochemical and Biophysical Research Communications |
| Garner JM, Ellison DW, Finkelstein D, et al. (2015) Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations. Plos One. 10: e0145052 |
| Garner JM, Ellison DW, Finkelstein D, et al. (2015) Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations. Plos One. 10: e0125838 |
| Garner JM, Fan M, Yang CH, et al. (2013) Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway. The Journal of Biological Chemistry. 288: 26167-76 |
| Orr WS, Denbo JW, Saab KR, et al. (2013) Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity. Plos One. 8: e51309 |
| Du Z, Whitt MA, Baumann J, et al. (2012) Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 32: 368-77 |